Meinolf Karthaus
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 55
- Neutropenia and Cancer Infections 53
- Cancer Treatment and Pharmacology 18
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility 40
- Emergency Medical Services top 0.5%
- Internal Medicine top 5%
- Hepatology top 2%
-
- Fungal Infections and Studies 33
-
- Gastric Cancer Management and Outcomes 19
-
- Genetic factors in colorectal cancer 18
-
- Nausea and vomiting management 16
- Co-authors
- Oliver A. CornelyDieter BuchheidtArnold GanserFernando RiveraAndrew J. UllmannLee S. SchwartzbergGianpiero FasolaJean-Luc Canon
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Meinolf Karthaus
176 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 2.0k
- Infectious Diseases 1.3k
- Emergency Medical Services 380
- Internal Medicine 157
- Hepatology 303
Countries citing papers authored by Meinolf Karthaus
This map shows the geographic impact of Meinolf Karthaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meinolf Karthaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meinolf Karthaus more than expected).
Fields of papers citing papers by Meinolf Karthaus
This network shows the impact of papers produced by Meinolf Karthaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meinolf Karthaus. The network helps show where Meinolf Karthaus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meinolf Karthaus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 32 | |
| 6 | 2022 | 3 | |
| 7 | 2017 | 25 | |
| 8 | 2017 | 79 | |
| 9 | PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancerbreakdown → | 2014 | 478 |
| 10 | 2011 | 12 | |
| 11 | 2009 | 13 | |
| 12 | Recent Epidemiology Trends of Candida Infections in Cancer and Non-Cancer Patients | 2008 | 1 |
| 13 | 2008 | 137 | |
| 14 | 2008 | 1 | |
| 15 | Choosing a study population for the evaluation of antifungal prophylaxis. Author's reply | 2005 | 1 |
| 16 | 2005 | 159 | |
| 17 | Dokumentierte Infektionen bei Neutropenie - Empfehlungen zu Diagnostik und Therapie | 2001 | 2 |
| 18 | 1999 | 16 | |
| 19 | 1999 | 2 | |
| 20 | 1999 | 8 |
About Meinolf Karthaus
Meinolf Karthaus is a scholar working on Oncology, Infectious Diseases and Clinical Biochemistry, having authored 186 papers that have together received 4.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (55 papers), Neutropenia and Cancer Infections (53 papers), Antifungal resistance and susceptibility (40 papers), Fungal Infections and Studies (33 papers), Gastric Cancer Management and Outcomes (19 papers), Genetic factors in colorectal cancer (18 papers), Cancer Treatment and Pharmacology (18 papers) and Nausea and vomiting management (16 papers). The work is most often cited by research in Oncology (2.0k citations), Infectious Diseases (1.3k citations) and Emergency Medical Services (380 citations). Meinolf Karthaus has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Oliver A. Cornely, Dieter Buchheidt, Arnold Ganser, Fernando Rivera, Andrew J. Ullmann, Lee S. Schwartzberg, Gianpiero Fasola, Jean-Luc Canon, Markus Ruhnke and J. Randolph Hecht. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.